Syndax Pharmaceuticals Inc. (SNDX)
NASDAQ · Healthcare
Syndax Pharmaceuticals Inc. Revenue 2015–2025
Syndax Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2015 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Syndax Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 64.9 M, a 223.64% increase year-over-year.
- Syndax Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 168.7 M, a 954.59% increase year-over-year.
- Syndax Pharmaceuticals Inc. annual revenue for 2025 was 172.4 M, a 627.84% increase from 2024.
- Syndax Pharmaceuticals Inc. annual revenue for 2024 was 23.7 M.
- Syndax Pharmaceuticals Inc. annual revenue for 2023 was 0.
- Syndax Pharmaceuticals Inc. annual revenue for 2022 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Syndax Pharmaceuticals Inc. Revenue — FAQ
Syndax Pharmaceuticals Inc. (SNDX) revenue over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Syndax Pharmaceuticals Inc.'s revenue?
Syndax Pharmaceuticals Inc. (SNDX) reported revenue of $172M for fiscal 2025.
Where can I see SNDX's revenue history?
The chart and table above show Syndax Pharmaceuticals Inc.'s revenue by year and by quarter, including the growth rate.